Brind.

Analyst ratings published on MarketBeat for Monopar Therapeutics, which trades on the Nasdaq stock exchange.

2 reports, 1 independent Updated Aug 27
Gone quiet
Reports
2
Developments
2
Repetition
0%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Analyst ratings published on MarketBeat for Monopar Therapeutics, which trades on the Nasdaq stock exchange.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Monopar Therapeutics received research reports and ratings from Cantor Fitzgerald and Morgan Stanley.1 source
  2. Analyst ratings published on MarketBeat for Monopar Therapeutics.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped